Developer docs
API playgroundTry for free, no card

Search company profiles

Briya

Full company profile

uuid00007wi

Namestring
Briya
Legal namestring
Bria Interoperability Ltd.
Websiteurl
briya.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Briya is an Israeli-American healthtech AI company founded in 2021 and headquartered in New York, with offices in Nashville and Tel Aviv. The company operates a blockchain-secured healthcare data exchange and research platform called Briya AIRE (AI Research Environment), which aggregates de-identified clinical data from hospitals, health systems, and research institutions globally. As of recent disclosures, Briya reports a network spanning 120 million+ patient journeys across multiple countries, with 22 analytics modules and 9 purpose-built AI agents built on proprietary medically-trained large language models. The platform supports FHIR and OMOP interoperability standards, offers on-premise AI deployment, and integrates with Epic's Connection Hub and InterSystems' health data fabric.

Briya serves a heterogeneous customer base spanning life sciences, biopharmaceutical companies, hospitals, and academic research institutions. Named enterprise customers include Merck (MSD), Biogen, Charité (Berlin), Casa Sollievo della Sofferenza (Italy), Tanner Health System (US), and Shaare Zedek Medical Center (Israel). The company operates a hybrid go-to-market combining direct enterprise sales for large biopharma and health system contracts with a freemium self-serve tier, a $25/month premium subscription, custom enterprise contracts, and distribution through AWS Marketplace. Briya holds ISO 27001 certification (June 2024) and HIPAA Expert Determination (May 2025), supporting regulated data workloads in US, EU, and Israeli markets. To date, Briya has raised approximately $17M across a $5.5M seed round (April 2022, led by Amiti Ventures) and an $11.5M Series A (September 2023, led by Team8), with participation from Insight Partners, Innocare Health Investments, and the George Kaiser Family Foundation.

Short descriptiontext

Briya is a healthcare AI company that aggregates de-identified clinical data from hospitals and research institutions via its blockchain-secured AIRE platform, serving biopharma, hospitals, and academic researchers across multiple countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare data exchange, real-world data platform, clinical research AI, medical research analytics, de-identified patient data
Industry3 codes
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAIAK
De-identification, Tokenization & Privacy-Preserving Data Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
NAICS code2 codes
  • Software Publishers5132
  • Software Publishers513210
Product category
Clinical Research Software
GTM motion5 records

Each record includes

Type, Description, Source

Revenue model5 records
1AIRE Freemium / Subscription
TypeFreemium
Description

Free public access to AIRE conversational AI platform for clinical, epidemiological and real-world evidence research; premium features available for $25 per month subscription, enabling monetization of advanced features while capturing a wide user base through freemium funnel.

prnewswire.com
2AIRE Premium Subscription
TypeSubscription Recurring
Description

Recurring $25/month premium tier of AIRE with advanced capabilities beyond free public access.

prnewswire.com
3Custom Dynamic Datasets (Data Monetization)
TypeData Monetisation
Description

Customized, condition-specific real-world data mastersets sold to life sciences and biopharma customers (e.g., Maternal Health, Duchenne, Alzheimer's, CKD, CLL, Ovarian Cancer, Breast Cancer, German RWD); researchers request specific variables and demographics and Briya provides a custom proposal.

briya.com
4Enterprise Platform Licensing (AWS Marketplace)
TypeSubscription Recurring
Description

Briya AIRE available for purchase via AWS Marketplace, enabling streamlined procurement and onboarding for healthcare and life science organizations with use cases across RWE generation, clinical development, HEOR, epidemiology, and health innovation.

briya.com
5Strategic Collaboration & Professional Services
TypeProfessional Services
Description

Strategic collaborations with biopharma (e.g., MSD, Biogen) and hospitals (e.g., Casa Sollievo della Sofferenza, Charité, Tanner Health System) for joint RWE data analysis, real-world evidence generation, and integrated research projects.

briya.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details4 tiers
1Free AIRE signup with browser-based access to harmonization, population and analytics agents, 22 analytics modules, and public clinical datasets
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free tier; no credit card required; organization email required for authentication.

briya.com
2Premium AIRE features at $25/month
ModelSubscriptionBilling cadenceMonthly
Notes

$25 per month; premium features for the conversational AI research platform.

prnewswire.com
3Enterprise AIRE via AWS Marketplace
ModelSubscriptionBilling cadenceAnnual
Notes

Available for purchase via AWS Marketplace; specific enterprise pricing not publicly disclosed; supports use cases across RWE, clinical development, HEOR, epidemiology.

briya.com
4Custom Dynamic Dataset (Quote-based)
ModelOtherBilling cadenceMulti-year contract
Notes

Custom proposal-based pricing for condition-specific real-world datasets (Maternal Health, Duchenne, Alzheimer's, CKD, CLL, Ovarian, Breast Cancer, German RWD); not publicly disclosed.

briya.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Briya AIRE (AIRE™)
Description

The AI Research Environment — a clinical-grade, browser-based AI research platform with purpose-built agents for harmonization, population, design, methodology, descriptives, and analytics; available on AWS Marketplace and as a free browser-based offering.

briya.com
Core offering1 text field

Briya operates a blockchain-secured healthcare data exchange platform that allows hospitals and life sciences organizations to share de-identified health data without moving or duplicating it. On top of this, it offers Briya AIRE, a clinical-grade AI Research Environment with 9 purpose-built AI agents and 22 analytics modules that enables researchers to query, analyze, and generate datasets from longitudinal real-world patient data using medically-trained LLMs and NLP. The company also sells condition-specific Dynamic Datasets (Maternal Health, Alzheimer's, Breast Cancer, etc.) to life sciences customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 10x acceleration in innovation
+5 more records
Product overview1 text field

Briya offers a unified platform-plus-modules architecture: the core offering is a blockchain-secured healthcare data exchange platform that connects hospitals and life-sciences organizations, on top of which sits Briya AIRE (the AI Research Environment) as the primary product. AIRE is extended by Dynamic Datasets — pre-built, disease-specific ready-to-use datasets (Maternal Health, Duchenne, Alzheimer's, CKD, CLL, Ovarian Cancer, Breast Cancer, etc.) — and by AIRE Agents, purpose-built autonomous agents that automate multi-step clinical research workflows using LLMs, RAG, and predictive analytics over de-identified real-world patient data.

Product and service3 records
1Briya AIRE (AI Research Environment)
CategoryAI Research Platform
Description

A clinical-grade, browser-based AI research environment with 9 purpose-built AI agents (Literature, Hypothesis, Population, Design, Methodology, Harmonization, Descriptives, Summary, Analytics) and 22 analytics modules that enables life-sciences researchers, hospitals, and academic users to run end-to-end clinical research workflows on de-identified real-world data without coding.

2Dynamic Datasets
CategoryReal-World Data
Description

Pre-built, disease-specific, revisitable and updatable real-world data mastersets (Maternal Health, Duchenne Muscular Dystrophy, Alzheimer's, Chronic Kidney Disease, Chronic Lymphocytic Leukemia, Ovarian Cancer, Breast Cancer, German RWD) sold to life sciences and biopharma customers for condition-specific research.

3Blockchain-Secured Healthcare Data Exchange Platform
CategoryData Exchange Infrastructure
Description

End-to-end blockchain-secured data exchange platform that allows hospitals and life sciences organizations to share de-identified health data without moving or duplicating it; data stays at the source with no warehouses, supporting FHIR/OMOP-compliant data models and three-layered de-identification.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership18 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-19
Description

Strategic partnership announced May 19, 2026 to integrate Briya's AI research platform with InterSystems' data infrastructure (powering over 1 billion health records globally). Enables healthcare and life sciences researchers to query longitudinal patient datasets using natural language while maintaining GDPR and HIPAA compliance. Demonstrated at InterSystems READY 2026 global summit.

Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2025-12-02
Description

Briya listed on Epic Connection Hub (December 2, 2025), enabling integration with Epic EHR systems. Tanner Health System became the first live implementation using Briya within its Epic EHR to improve data sharing and healthcare research.

Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-10-23
Description

Briya AIRE available for purchase via AWS Marketplace (October 23, 2025), enabling streamlined procurement and onboarding for healthcare and life science organizations. Customers can initiate AIRE procurement through their AWS portal, simplifying security and compliance reviews.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-10
Description

Selected as one of five contributors from hundreds of applications to the Biogen HLTH Rare Disease Accelerator (June 10, 2025). Supports Biogen's rare disease portfolio (Friedreich's Ataxia, SMA, ALS) with planned expansion into liver health. Briya's AI/NLP and complete longitudinal patient journey capabilities are central to this partnership.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-05-27
Description

Italian hospital and research institution partnership announced May 27, 2025 to make European healthcare data more accessible to researchers worldwide. Casa Sollievo della Sofferenza treats over 200,000 patients annually and was ranked #1 hospital in Southern Italy by Newsweek 2024. Dr. Gino Gumirato (CEO) is engaged in enabling access to high-quality Italian RWD. Francesco Giuliani (Head of Research and Innovation) integrates Briya AI Copilot.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-03-28
Description

Tapped by Decode as new precision medicine data-sharing partner (March 28, 2023).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-12-02
Description

Cofounded by Neureka® and Briya to develop life-saving interventions for SUDEP (Sudden Unexpected Death in Epilepsy). Cove Neurosciences joined the alliance in June 2023.

8Intel Ignite
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-11-10
Description

Joined Intel Ignite's 7th cohort in Tel Aviv (November 10, 2022), an exclusive accelerator program for deep tech startups. Selected from over 200 applicants.

intelignite.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-09-21
Description

Joined UC Berkeley's prestigious Health Engine 3rd cohort (September 21, 2022), a health-tech accelerator program.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Renowned German hospital serving as trusted healthcare partner in Briya's German RWD network. Part of a partnership enabling access to 11M+ de-identified German patient records, 118M patient-doctor interactions, 51M diagnosis-tagged visits, 68M service records with full GDPR compliance.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Strategic collaboration announced October 10, 2024 for innovative RWE data analysis projects. Udi Cohen, MSD IL Commercial Operations Director, said: 'Briya's data curation techniques shed new light on analyzing clinical data to generate insights.'

12Cove Neurosciences
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Joined the SUDEP Data Alliance (cofounded by Neureka® and Briya) on June 29, 2023 to develop life-saving interventions for SUDEP.

briya.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnered with Briya (Dr. Tzvi Sheleg) on ISPOR Europe 2024 study on aspirin use during pregnancy demonstrating the value of NLP for uncovering critical data in clinical research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Israeli medical center using Briya's advanced NLP capabilities to identify patients with 'at-risk MASH' (fibrosis stage ≥ F2) directly from unstructured clinical data, enabling timely referral to hepatology and access to emerging treatments. Gadi Lalazar, M.D., Director of Hepatology, is referenced as a customer advocate.

15Prof. Siegal Sadetzki
Strategic tierFlagshipTypeOthers
Description

Renowned public health expert, epidemiologist, and former Chief Epidemiology Officer at Briya; joined in June 2024 from Israeli MoH where she led during COVID-19. She shapes Briya's epidemiologically-aware AI research vision and is a frequent contributor.

briya.com
16Prof. Jonathan Samet, MD, MS
Strategic tierFlagshipTypeOthers
Description

Appointed Chief Epidemiologist of Briya (May 27, 2026) to lead integration of epidemiological methodology into the AIRE research engine. Brings 40+ years of experience from Johns Hopkins and the University of Colorado; member of the National Academy of Medicine.

prnewswire.com
17Fabio Lievano, M.D.
Strategic tierMinorTypeOthers
Description

Scientific Advisor to Briya; VP Safety Science at Abbvie. Provides scientific and pharmaceutical industry guidance.

briya.com
18Moshe Bar Siman Tov
Strategic tierMinorTypeOthers
Description

Former Board Advisor and Former Director General of the Israeli Ministry of Health. Provides policy-level healthcare expertise.

briya.com
Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global clinical research network enabling protocol design, feasibility, and real-world evidence across 200+ healthcare organizations; competes head-on with Briya AIRE for pharma-sponsored RWE studies.

TypeBroad incumbent
Description

Largest clinical research and real-world evidence organization globally; overlaps with Briya on biopharma RWE, HEOR, and study feasibility but as part of a much broader CRO and data services portfolio.

TypeDirect peer
Description

Roche-owned oncology real-world data and EHR-linked analytics platform; the closest direct competitor in the 'AI-enabled harmonization of clinical real-world data for life sciences' category that Briya targets.

4Tempus
TypeBroad incumbent
Description

Large AI-powered precision medicine platform combining multi-modal clinical and molecular data for biopharma and providers; broader scope than Briya but overlapping on AI-driven clinical research and condition-specific datasets.

TypeDirect peer
Description

Healthcare data connectivity and de-identification layer for linking real-world data across providers; competes with Briya's blockchain-secured, on-premise data exchange architecture for hospital-to-life-sciences data flows.

TypeEmerging player
Description

Real-world evidence generation service using de-identified patient data to answer clinician and life-sciences questions; an emerging peer with strong overlap on the 'chat-with-data' research workflow that Briya AIRE delivers.

TypeBroad incumbent
Description

Healthcare analytics and data platform for health systems, serving similar enterprise hospital buyers as Briya but with a broader focus on operational and clinical analytics rather than life-sciences RWE.

TypeBroad incumbent
Description

Enterprise data platform with deep adoption among large healthcare systems, life sciences, and government health agencies; competes with Briya for hospital data harmonization and analytics workloads at the high end of the market.

TypeDirect peer
Description

Real-world evidence analytics platform used by top biopharma and regulators (including FDA collaborations) for RWE generation; a direct peer for Briya's AI-driven RWE and HEOR use cases.

10Mendel
TypeEmerging player
Description

AI platform that structures and reasons over unstructured clinical text for life-sciences research; a focused emerging peer to Briya's medically-trained LLM and NLP capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Briya

Clinical Research Softwarebriya.com

Briya is a healthcare AI company that aggregates de-identified clinical data from hospitals and research institutions via its blockchain-secured AIRE platform, serving biopharma, hospitals, and academic researchers across multiple countries.

What Briya does

Briya is an Israeli-American healthtech AI company founded in 2021 and headquartered in New York, with offices in Nashville and Tel Aviv. The company operates a blockchain-secured healthcare data exchange and research platform called Briya AIRE (AI Research Environment), which aggregates de-identified clinical data from hospitals, health systems, and research institutions globally. As of recent disclosures, Briya reports a network spanning 120 million+ patient journeys across multiple countries, with 22 analytics modules and 9 purpose-built AI agents built on proprietary medically-trained large language models. The platform supports FHIR and OMOP interoperability standards, offers on-premise AI deployment, and integrates with Epic's Connection Hub and InterSystems' health data fabric.

Briya serves a heterogeneous customer base spanning life sciences, biopharmaceutical companies, hospitals, and academic research institutions. Named enterprise customers include Merck (MSD), Biogen, Charité (Berlin), Casa Sollievo della Sofferenza (Italy), Tanner Health System (US), and Shaare Zedek Medical Center (Israel). The company operates a hybrid go-to-market combining direct enterprise sales for large biopharma and health system contracts with a freemium self-serve tier, a $25/month premium subscription, custom enterprise contracts, and distribution through AWS Marketplace. Briya holds ISO 27001 certification (June 2024) and HIPAA Expert Determination (May 2025), supporting regulated data workloads in US, EU, and Israeli markets. To date, Briya has raised approximately $17M across a $5.5M seed round (April 2022, led by Amiti Ventures) and an $11.5M Series A (September 2023, led by Team8), with participation from Insight Partners, Innocare Health Investments, and the George Kaiser Family Foundation.

Briya firmographics

Firmographics
Name
Briya
Legal name
Bria Interoperability Ltd.
Website
https://briya.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
51–100 employees
Short description
Briya is a healthcare AI company that aggregates de-identified clinical data from hospitals and research institutions via its blockchain-secured AIRE platform, serving biopharma, hospitals, and academic researchers across multiple countries.
Ownership category
akta.pro rank

Briya industry classification

Industry
Product category
Clinical Research Software
NAICS
Software Publishers (5132), Software Publishers (513210)
akta.pro industry
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAIAK
De-identification, Tokenization & Privacy-Preserving Data Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance

Keywords

  • Healthcare data exchange
  • Real-world data platform
  • Clinical research AI
  • Medical research analytics
  • De-identified patient data

Where Briya is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Briya business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. AIRE Freemium / Subscription: Free public access to AIRE conversational AI platform for clinical, epidemiological and real-world evidence research; premium features available for $25 per month subscription, enabling monetization of advanced features while capturing a wide user base through freemium funnel.
  2. AIRE Premium Subscription: Recurring $25/month premium tier of AIRE with advanced capabilities beyond free public access.
  3. Custom Dynamic Datasets (Data Monetization): Customized, condition-specific real-world data mastersets sold to life sciences and biopharma customers (e.g., Maternal Health, Duchenne, Alzheimer's, CKD, CLL, Ovarian Cancer, Breast Cancer, German RWD); researchers request specific variables and demographics and Briya provides a custom proposal.
  4. Enterprise Platform Licensing (AWS Marketplace): Briya AIRE available for purchase via AWS Marketplace, enabling streamlined procurement and onboarding for healthcare and life science organizations with use cases across RWE generation, clinical development, HEOR, epidemiology, and health innovation.
  5. Strategic Collaboration & Professional Services: Strategic collaborations with biopharma (e.g., MSD, Biogen) and hospitals (e.g., Casa Sollievo della Sofferenza, Charité, Tanner Health System) for joint RWE data analysis, real-world evidence generation, and integrated research projects.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree AIRE signup with browser-based access to harmonization, population and analytics agents, 22 analytics modules, and public clinical datasets
SubscriptionMonthlyPremium AIRE features at $25/month
SubscriptionAnnualEnterprise AIRE via AWS Marketplace
OtherMulti-year contractCustom Dynamic Dataset (Quote-based)

Go-to-market motion5 records

Distribution channels5 records

Marketing channels9 records

Briya product offering

Product offering

Core offering

Briya operates a blockchain-secured healthcare data exchange platform that allows hospitals and life sciences organizations to share de-identified health data without moving or duplicating it. On top of this, it offers Briya AIRE, a clinical-grade AI Research Environment with 9 purpose-built AI agents and 22 analytics modules that enables researchers to query, analyze, and generate datasets from longitudinal real-world patient data using medically-trained LLMs and NLP. The company also sells condition-specific Dynamic Datasets (Maternal Health, Alzheimer's, Breast Cancer, etc.) to life sciences customers.

Product overview

Briya offers a unified platform-plus-modules architecture: the core offering is a blockchain-secured healthcare data exchange platform that connects hospitals and life-sciences organizations, on top of which sits Briya AIRE (the AI Research Environment) as the primary product. AIRE is extended by Dynamic Datasets — pre-built, disease-specific ready-to-use datasets (Maternal Health, Duchenne, Alzheimer's, CKD, CLL, Ovarian Cancer, Breast Cancer, etc.) — and by AIRE Agents, purpose-built autonomous agents that automate multi-step clinical research workflows using LLMs, RAG, and predictive analytics over de-identified real-world patient data.

Differentiator

Problem solved

Functional benefit

Brands

  • Briya AIRE (AIRE™): The AI Research Environment — a clinical-grade, browser-based AI research platform with purpose-built agents for harmonization, population, design, methodology, descriptives, and analytics; available on AWS Marketplace and as a free browser-based offering.

Products and services

  • Briya AIRE (AI Research Environment) A clinical-grade, browser-based AI research environment with 9 purpose-built AI agents (Literature, Hypothesis, Population, Design, Methodology, Harmonization, Descriptives, Summary, Analytics) and 22 analytics modules that enables life-sciences researchers, hospitals, and academic users to run end-to-end clinical research workflows on de-identified real-world data without coding.
  • Dynamic Datasets Pre-built, disease-specific, revisitable and updatable real-world data mastersets (Maternal Health, Duchenne Muscular Dystrophy, Alzheimer's, Chronic Kidney Disease, Chronic Lymphocytic Leukemia, Ovarian Cancer, Breast Cancer, German RWD) sold to life sciences and biopharma customers for condition-specific research.
  • Blockchain-Secured Healthcare Data Exchange Platform End-to-end blockchain-secured data exchange platform that allows hospitals and life sciences organizations to share de-identified health data without moving or duplicating it; data stays at the source with no warehouses, supporting FHIR/OMOP-compliant data models and three-layered de-identification.

Quantifiable outcome

  • 10x acceleration in innovation
  • +5 more outcomes

Companies that use Briya

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Briya technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability9 records

Feature8 records

Briya partnerships and signals

Strategic signal

Partnerships

18 partnerships are on record, tiered flagship, core and minor.

  • InterSystemsflagshipStrategic or Co-development Partner · 19 May 2026Strategic partnership announced May 19, 2026 to integrate Briya's AI research platform with InterSystems' data infrastructure (powering over 1 billion health records globally). Enables healthcare and life sciences researchers to query longitudinal patient datasets using natural language while maintaining GDPR and HIPAA compliance. Demonstrated at InterSystems READY 2026 global summit.
  • Epic (Connection Hub)flagshipTechnology or Integration · 2 December 2025Briya listed on Epic Connection Hub (December 2, 2025), enabling integration with Epic EHR systems. Tanner Health System became the first live implementation using Briya within its Epic EHR to improve data sharing and healthcare research.
  • AWS (Amazon Web Services) MarketplaceflagshipChannel Partner/ Reseller/ Distributor · 23 October 2025Briya AIRE available for purchase via AWS Marketplace (October 23, 2025), enabling streamlined procurement and onboarding for healthcare and life science organizations. Customers can initiate AIRE procurement through their AWS portal, simplifying security and compliance reviews.
  • Biogen HLTH Rare Disease AcceleratorcoreStrategic or Co-development Partner · 10 June 2025Selected as one of five contributors from hundreds of applications to the Biogen HLTH Rare Disease Accelerator (June 10, 2025). Supports Biogen's rare disease portfolio (Friedreich's Ataxia, SMA, ALS) with planned expansion into liver health. Briya's AI/NLP and complete longitudinal patient journey capabilities are central to this partnership.
  • Casa Sollievo della SofferenzaflagshipStrategic or Co-development Partner · 27 May 2025Italian hospital and research institution partnership announced May 27, 2025 to make European healthcare data more accessible to researchers worldwide. Casa Sollievo della Sofferenza treats over 200,000 patients annually and was ranked #1 hospital in Southern Italy by Newsweek 2024. Dr. Gino Gumirato (CEO) is engaged in enabling access to high-quality Italian RWD. Francesco Giuliani (Head of Research and Innovation) integrates Briya AI Copilot.
  • Decode HealthminorStrategic or Co-development Partner · 28 March 2023Tapped by Decode as new precision medicine data-sharing partner (March 28, 2023).
  • SUDEP Data Alliance (with Neureka®)coreStrategic or Co-development Partner · 2 December 2022Cofounded by Neureka® and Briya to develop life-saving interventions for SUDEP (Sudden Unexpected Death in Epilepsy). Cove Neurosciences joined the alliance in June 2023.
  • Intel IgniteminorStrategic or Co-development Partner · 10 November 2022Joined Intel Ignite's 7th cohort in Tel Aviv (November 10, 2022), an exclusive accelerator program for deep tech startups. Selected from over 200 applicants.
  • UC Berkeley Health EngineminorStrategic or Co-development Partner · 21 September 2022Joined UC Berkeley's prestigious Health Engine 3rd cohort (September 21, 2022), a health-tech accelerator program.
  • CharitéflagshipStrategic or Co-development PartnerRenowned German hospital serving as trusted healthcare partner in Briya's German RWD network. Part of a partnership enabling access to 11M+ de-identified German patient records, 118M patient-doctor interactions, 51M diagnosis-tagged visits, 68M service records with full GDPR compliance.
  • MSD (Merck)flagshipStrategic or Co-development PartnerStrategic collaboration announced October 10, 2024 for innovative RWE data analysis projects. Udi Cohen, MSD IL Commercial Operations Director, said: 'Briya's data curation techniques shed new light on analyzing clinical data to generate insights.'
  • Cove NeurosciencesminorStrategic or Co-development PartnerJoined the SUDEP Data Alliance (cofounded by Neureka® and Briya) on June 29, 2023 to develop life-saving interventions for SUDEP.
  • Galilee Medical CenterminorStrategic or Co-development PartnerPartnered with Briya (Dr. Tzvi Sheleg) on ISPOR Europe 2024 study on aspirin use during pregnancy demonstrating the value of NLP for uncovering critical data in clinical research.
  • Shaare Zedek Medical CentercoreStrategic or Co-development PartnerIsraeli medical center using Briya's advanced NLP capabilities to identify patients with 'at-risk MASH' (fibrosis stage ≥ F2) directly from unstructured clinical data, enabling timely referral to hepatology and access to emerging treatments. Gadi Lalazar, M.D., Director of Hepatology, is referenced as a customer advocate.
  • Prof. Siegal SadetzkiflagshipOthersRenowned public health expert, epidemiologist, and former Chief Epidemiology Officer at Briya; joined in June 2024 from Israeli MoH where she led during COVID-19. She shapes Briya's epidemiologically-aware AI research vision and is a frequent contributor.
  • Prof. Jonathan Samet, MD, MSflagshipOthersAppointed Chief Epidemiologist of Briya (May 27, 2026) to lead integration of epidemiological methodology into the AIRE research engine. Brings 40+ years of experience from Johns Hopkins and the University of Colorado; member of the National Academy of Medicine.
  • Fabio Lievano, M.D.minorOthersScientific Advisor to Briya; VP Safety Science at Abbvie. Provides scientific and pharmaceutical industry guidance.
  • Moshe Bar Siman TovminorOthersFormer Board Advisor and Former Director General of the Israeli Ministry of Health. Provides policy-level healthcare expertise.

Scale indicators13 records

Recent moves12 records

Expansion highlights7 records

Briya competitors and assessment

Company assessment

Direct peers

  • TriNetX: Global clinical research network enabling protocol design, feasibility, and real-world evidence across 200+ healthcare organizations; competes head-on with Briya AIRE for pharma-sponsored RWE studies.
  • Flatiron Health: Roche-owned oncology real-world data and EHR-linked analytics platform; the closest direct competitor in the 'AI-enabled harmonization of clinical real-world data for life sciences' category that Briya targets.
  • Datavant: Healthcare data connectivity and de-identification layer for linking real-world data across providers; competes with Briya's blockchain-secured, on-premise data exchange architecture for hospital-to-life-sciences data flows.
  • Aetion: Real-world evidence analytics platform used by top biopharma and regulators (including FDA collaborations) for RWE generation; a direct peer for Briya's AI-driven RWE and HEOR use cases.

Broad incumbents

  • IQVIA: Largest clinical research and real-world evidence organization globally; overlaps with Briya on biopharma RWE, HEOR, and study feasibility but as part of a much broader CRO and data services portfolio.
  • Tempus: Large AI-powered precision medicine platform combining multi-modal clinical and molecular data for biopharma and providers; broader scope than Briya but overlapping on AI-driven clinical research and condition-specific datasets.
  • Health Catalyst: Healthcare analytics and data platform for health systems, serving similar enterprise hospital buyers as Briya but with a broader focus on operational and clinical analytics rather than life-sciences RWE.
  • Palantir Foundry: Enterprise data platform with deep adoption among large healthcare systems, life sciences, and government health agencies; competes with Briya for hospital data harmonization and analytics workloads at the high end of the market.

Emerging players

  • Atropos Health: Real-world evidence generation service using de-identified patient data to answer clinician and life-sciences questions; an emerging peer with strong overlap on the 'chat-with-data' research workflow that Briya AIRE delivers.
  • Mendel: AI platform that structures and reasons over unstructured clinical text for life-sciences research; a focused emerging peer to Briya's medically-trained LLM and NLP capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

Briya social profiles

Digital presence

Briya compliance and trust

Trust signal

Compliance3 records

Briya financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Briya leadership team

Management profile

Number of profiles

Profiles10 records

Briya funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Briya M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Briya

What does Briya do?

Briya operates a blockchain-secured healthcare data exchange platform that allows hospitals and life sciences organizations to share de-identified health data without moving or duplicating it. On top of this, it offers Briya AIRE, a clinical-grade AI Research Environment with 9 purpose-built AI agents and 22 analytics modules that enables researchers to query, analyze, and generate datasets from longitudinal real-world patient data using medically-trained LLMs and NLP. The company also sells condition-specific Dynamic Datasets (Maternal Health, Alzheimer's, Breast Cancer, etc.) to life sciences customers.

Is Briya a public or private company?

Briya is a private company. It is classified as venture growth investor backed and is currently operating.

When was Briya founded?

Briya was founded in 2022. It employs 51 to 100 people.

Where is Briya based?

Briya is headquartered in New York, United States, in the North America region.

How does Briya make money?

Five revenue lines are on record. AIRE Freemium / Subscription is the primary driver. The others are AIRE Premium Subscription, custom Dynamic Datasets (Data Monetization), enterprise Platform Licensing (AWS Marketplace) and strategic Collaboration & Professional Services.

Who are Briya's main competitors?

Direct peers on record are TriNetX, Flatiron Health, Datavant and Aetion. Broad incumbents are IQVIA, Tempus, Health Catalyst and Palantir Foundry. Emerging players are Atropos Health and Mendel.

Does Briya have an API?

No public API is recorded for Briya.

What industry is Briya in?

Briya's product category is Clinical Research Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 5132.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBriya AIRE Study of 32 Years of U.S. Data Reveals Worsening Self-Reported Health in Midlife but Improvement at Older AgesBriya, NYU, and Johns Hopkins used AIRE to harmonize 6.4 million U.S. BRFSS responses from 1993-2024, revealing divergent age-specific health trends. Fair or poor self-rated health rose from 13.8% to 21.6% among adults aged 50-54, while falling from 36.2% to 26.1% among those 80 and older. The findings suggest morbidity is expanding in midlife while postponed at older ages.PR NewswireBriya AIRE Study of 32 Years of U.S. Data Reveals Worsening Self-Reported Health in Midlife but Improvement at Older AgesBriya, NYU, and Johns Hopkins used AIRE to harmonize 6.4 million U.S. BRFSS responses from 1993-2024, revealing divergent age-specific health trends. Fair or poor self-rated health rose from 13.8% to 21.6% among adults aged 50-54, while falling from 36.2% to 26.1% among those 80 and older. The findings suggest morbidity is expanding in midlife while being postponed at older ages.citybizBriya Appoints Jason Hein as Chief Commercial Officer to Expand AI-Powered Research PlatformBriya appointed Jason Hein as Chief Commercial Officer to lead global expansion of its AI-powered clinical research platform AIRE. Hein joins from RTI International, where he oversaw equity investments and strategic partnerships. The company aims to expand adoption among CROs, HEOR consultancies, and research institutions.PR NewswireBriya Appoints CCO Jason Hein to Bring AI-Native Evidence Generation to Global Research Organizations and Life SciencesBriya appointed Jason Hein as Chief Commercial Officer to scale its AIRE scientific AI platform. The hire follows a market where drugmakers spend over $25 billion annually on real-world evidence, with two-thirds on expert analysis. Hein will lead global commercial strategy, targeting CROs, HEOR consultancies, and research institutes.Medical Device NetworkAI’s use on existing radiology reports sees 360% rise in steatotic liver patient identificationBriya's AIRE AI platform analyzed 28,795 abdominal ultrasound reports and identified 4,036 additional patients with steatotic liver disease, expanding the study population by 360% from 1,122 to 5,158. The analysis found 78% of these patients lacked a structured EHR diagnosis, highlighting a gap in unstructured report data.PR NewswireNew Study Shows Briya's AIRE AI Research Platform Expands Steatotic Liver Disease Identification by 360% Using Previously Overlooked Radiology DataBriya AIRE's study of 28,795 abdominal ultrasound reports identified 360% more steatotic liver patients than structured data alone, finding 78% were only in unstructured radiology reports. The analysis added 4,036 patients, expanding the population from 1,122 to 5,158, with 94% precision and 97% recall. Results will be presented at AASLD's The Liver Meeting 2026.PR NewswireBriya Opens Free Access to AIRE™, Bringing a Transparent AI-Powered Medical Research Platform to the Global Scientific CommunityBriya announced on June 15, 2026 the launch of free access to AIRE, a conversational AI platform designed for clinical, epidemiological, and real-world evidence research, providing healthcare researchers with a transparent, browser-based tool for scientific inquiry. The platform enables researchers to design cohorts, validate endpoints, analyze treatment pathways and extract clinical insights from unstructured data without coding expertise, with premium features available for $25 per month. The launch reflects a broader trend of free-access AI platforms expanding into specialized professional markets, aiming to democratize access to advanced analytical capabilities that have historically been concentrated within large academic medical centers and pharmaceutical organizations.Pulse 2.0Briya Appoints Professor Jonathan M. Samet As Chief Epidemiologist To Strengthen AI-Driven Clinical ResearchBriya appointed Professor Jonathan M. Samet as Chief Epidemiologist to lead integration of epidemiological methodology into its AIRE research engine. The role aims to combine AI with rigorous scientific research practices, and the company will demonstrate its epidemiology-aware capabilities at HLTH Europe.PR NewswireBriya Appoints Professor Jonathan Samet, MD, MS as Chief Epidemiologist, Embedding Academic Rigor in AI-Driven Clinical ResearchBriya, a New York-based healthtech AI company, announced the appointment of Professor Jonathan Samet as Chief Epidemiologist to lead integration of epidemiological methodology into its AIRE™ research engine for clinical and biomedical research. Prof. Samet brings over 40 years of experience from institutions including Johns Hopkins and the University of Colorado, and is a member of the National Academy of Medicine. The appointment aims to strengthen scientific rigor and build trust in AI-driven medical research workflows by embedding proven epidemiological principles into Briya's AI platform.PR NewswireBriya Partners with InterSystems to Launch AI-Powered Conversation Research Capabilities Across Global MarketsBriya, a health AI technology company, announced a strategic partnership with InterSystems, a data technology provider powering over one billion health records globally, to integrate Briya's AI research platform with InterSystems' data infrastructure. The collaboration enables healthcare and life sciences researchers to query longitudinal patient datasets using natural language, accelerating therapy development and real-world evidence generation while maintaining GDPR and HIPAA compliance. The partnership was demonstrated at the InterSystems READY 2026 global summit, with both companies positioning it as a solution to bridge fragmented health data and advance medical discovery.